A. Crespo

Three-component assembly of structurally diverse 2-aminopyrimidine-5-carbonitriles.

Cristina Val, J. Azuaje, E. Sotelo, 2013, ACS combinatorial science.

Exploring the influence of the substituent at position 4 in a series of 3,4-dihydropyrimidin-2(1H)-one A2B adenosine receptor antagonists

J. Azuaje, M. Loza, E. Sotelo, 2017, Chemistry of Heterocyclic Compounds.

3,4-Dihydropyrimidin-2(1H)-ones as Antagonists of the Human A2B Adenosine Receptor: Optimization, Structure-Activity Relationship Studies, and Enantiospecific Recognition.

J. Åqvist, X. García‐Mera, J. Azuaje, 2020, Journal of medicinal chemistry.

3-Oxopyridazin-5-yl-Chalcone Hybrids : Potent Antiplatelet Agents That Prevent Glycoprotein IIb/IIIa Activation

M. Loza, E. Sotelo, Alberto Coelho, 2017 .

Supported TBD-assisted solution phase diversification of formyl-aza-heterocycles through alkylation-knoevenagel one pot sequences.

Alberto Coelho, Artur M. S. Silva, Abdelaziz El Maatougui, 2011, Combinatorial chemistry & high throughput screening.

Convergent assembly of structurally diverse quinazolines.

E. Sotelo, Alberto Coelho, A. Crespo, 2011, Organic & biomolecular chemistry.

Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes.

X. García‐Mera, J. Azuaje, E. Sotelo, 2016, Journal of medicinal chemistry.

Discovery of 3,4-Dihydropyrimidin-2(1H)-ones As a Novel Class of Potent and Selective A2B Adenosine Receptor Antagonists.

X. García‐Mera, J. Azuaje, M. Loza, 2013, ACS medicinal chemistry letters.

Pyridazines part 41: synthesis, antiplatelet activity and SAR of 2,4,6-substituted 5-(3-oxo-3-phenylprop-1-en-1-yl)- or 5-(3-phenylprop-2-enoyl)pyridazin-3(2H)-ones.

E. Sotelo, Alberto Coelho, B. Maes, 2006, Bioorganic & medicinal chemistry letters.

Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A1 Antagonists

X. García‐Mera, Cristina Val, M. Loza, 2022, Journal of medicinal chemistry.